iBio (IBIO) Receivables - Net (2011 - 2025)

iBio's (IBIO) quarterly Receivables - Net came in at $65000.0 in Q3 2025, down 7.14% on a QoQ basis from $70000.0 in Q1 2023.

iBio (IBIO) Receivables - Net (2011 - 2025) Analysis & Trends

iBio (IBIO) has 14 years of Receivables - Net data on file, last reported at $65000.0 in Q3 2025.

  • On a quarterly basis, Receivables - Net changed N/A year-over-year to $65000.0 in Q3 2025; TTM through Sep 2025 was $65000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $1.0 million, up 134.74% from the prior year.
  • Receivables - Net for Q3 2025 stood at $65000.0, down from $70000.0 in the prior quarter.
  • Over the last five years, Receivables - Net for IBIO reached as high as $1.1 million in Q3 2022 and fell as low as $65000.0 in Q3 2025.
  • Historically, Receivables - Net has averaged $529500.0 across 4 years, with a median of $406500.0 in 2021.
  • Across the five-year window, Receivables - Net jumped 773.87% in 2022 and plunged 93.03% in 2023, its largest moves.
  • Year by year, Receivables - Net stood at $111000.0 in 2021, then soared by 773.87% to $970000.0 in 2022, then plunged by 92.78% to $70000.0 in 2023, then slipped by 7.14% to $65000.0 in 2025.
  • Per Business Quant data, the three most recent Receivables - Net figures were $65000.0 in Q3 2025, $70000.0 in Q1 2023, and $970000.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn -
2 Nanobiotix 1,909.44 Bn 1,909.38 Bn -
3 Akari Therapeutics 989.71 Bn 989.71 Bn -
4 BeOne Medicines 471.58 Bn 466.79 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.97 Bn 114.72 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.93 Bn 61.18 Bn 3.31 Bn
7 Belite Bio 62.68 Bn 62.68 Bn -
8 Argenx Se 55.80 Bn 50.61 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.37 Bn 34.36 Bn 959.66 Mn
10 iBio 166.24 Mn 166.24 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 65,000.00
Sep 30, 2025 65,000.00
Mar 31, 2023 70,000.00
Mar 31, 2023 70,000.00
Dec 31, 2022 970,000.00
Dec 31, 2022 970,000.00
Sep 30, 2022 1.06 Mn
Sep 30, 2022 1.06 Mn
Jun 30, 2022 1.00 Mn
Jun 30, 2022 1.00 Mn
Mar 31, 2022 1.00 Mn
Mar 31, 2022 1.00 Mn
Dec 31, 2021 111,000.00
Dec 31, 2021 111,000.00
Sep 30, 2021 207,000.00
Sep 30, 2021 207,000.00
Jun 30, 2021 426,000.00
Jun 30, 2021 426,000.00
Mar 31, 2021 387,000.00
Mar 31, 2021 387,000.00